Botulinum toxin management of upper facial rhytidosis and blepharospasm

Otolaryngologic Clinics of North America

Volumn 38, Issue 5, 2005, Pages 887-902

  Seiff, Stuart R ^a   Zwick, Orin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANESTHETIC AGENT; BACLOFEN; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; CLONAZEPAM; DEANOL; EMLA; HALOPERIDOL; LEVODOPA; MEPROBAMATE; PHENYTOIN; TETRABENAZINE; TRIHEXYPHENIDYL;

ACETYLCHOLINE RELEASE; ANTIBODY PRODUCTION; BLEPHAROSPASM; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIPLOPIA; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG SAFETY; DRUG STORAGE; DYSKINESIA; DYSTONIA; ECTROPION; ENTROPION; EPIPHORA; FACE MUSCLE; FACIAL NERVE PARALYSIS; FOOD AND DRUG ADMINISTRATION; HEMATOMA; HEMIFACIAL SPASM; HUMAN; INJECTION PAIN; INJECTION SITE REACTION; LAGOPHTHALMOS; MEIGE DISEASE; MUSCLE RESECTION; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NERVE ENDING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOPHOBIA; PTOSIS; REVIEW; SKIN DEFECT; VISUAL IMPAIRMENT; WRINKLE;

BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; HEMIFACIAL SPASM; HUMANS; NEUROMUSCULAR AGENTS; SKIN AGING;

EID: 26444551067     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2005.03.005     Document Type: Review

References (37)

1. A.B. Scott Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery Ophthalmology 87 1980 1044 1049
2. L.L. Simpson The origin, structure, and pharmacological activity of botulinum toxin Pharmacol Rev 33 1981 155 188
3. P. Greene, U. Kang, and S. Fahn Double-blind placebo-controlled trial of botulinum injections in the treatment of spasmodic torticollis Neurology 40 1990 1213 1218
4. T. Mezaki, R. Kaji, and N. Nohora Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study Neurology 45 1995 506 508
5. R.M. Siatkowski, A. Tyutyunikov, and A.W. Biglan Serum antibody production to botulinum A toxin Ophthalmology 100 1993 1861 1866
6. M. Zuber, M. Sebald, and N. Bathien Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance Neurology 43 1993 1715 1718
7. J. Jankovic, K. Schwartz, and D.T. Donovan Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm J Neurol Neurosurg Psychiatry 53 1990 633 639
8. M.G. Gartlan, and H.T. Hoffman Crystalline preparation of botulinum toxin type A (Botox): degradation in potency with storage Otolarygol Head Neck Surg 108 1993 135
9. A. Garcia, and J.E. Fulton Cosmetic denervation of the muscles of facial expression with botulinum toxin Dermatol Surg 22 1996 39
10. R.R. Sloop, B.A. Cole, and R.O. Escutin Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use Neurology 48 1997 149
11. M.A. Jabor, R. Kaushik, and P. Shayani Efficacy of reconstituted and stored botulinum toxin type A: an electrophysiologic and visual study in the auricular muscle of the rabbit Plast Reconst Surg 111 2003 2419 2426
12. D.M. Hexsel, A.T. Almeida, and M. Rutowitsch Multicenter, double-blind study of the efficacy of injections with botulinum toxin type a reconstituted up to six consecutive weeks before application Dermatol Surg 29 2003 523 529
13. M.F. Soylev, N. Kocak, and B. Kuvaki Anesthesia with EMLA cream for botulinum A toxin injection into eyelids Ophthalmologica 216 2002 355 358
14. D.M. Kwiat, T.A. Bersani, and A. Bersani Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline Ophthal Plast Reconstr Surg 20 2004 186 189
15. W.H. Jost, and A. Kohl Botulinum toxin: evidence based medicine criteria in blepharospasm and hemifacial spasm J Neurol 248 Suppl 1 2001 21 24
16. N. Shorr, S.R. Seiff, and J. Kopelman The use of botulinum toxin in blepharospasm Am J Ophthalmol 99 1985 542 546
17. R.L. Anderson, B.C. Patel, and J.B. Holds Blepharospasm: past, present and future Ophthal Plast Reconstr Surg 14 1998 305 317
18. B.R. Frueh, and D.C. Musch Treatment of facial spasm with botulinum toxin: an interim report Ophthalmology 93 1986 917 923
19. J.D. McCann, S.H. Ugurbas, and R.A. Goldberg Benign essential blepharospasm Int Ophthalmol Clin 42 2002 113 121
20. B.R. Freuh, D.P. Felt, and T.H. Wojno Treatment of blepharospasm with botulinum toxin: a preliminary report Arch Ophthalmol 102 1984 1464 1468
21. A.B. Scott, E.G. Kennedy, and H.A. Stubbs Botulinum A toxin injection as a treatment for blepharospasm Arch Ophthalmol 103 1985 347 350
22. E.A. Tsoy, E.G. Buckley, and J.J. Dutton Treatment of blepharospasm with botulinum toxin Am J Ophthalmol 99 1985 176 179
23. J.D. Holds, K. Alderson, and S.G. Fogg Motor nerve sprouting in human orbicularis muscle after botulinum A injection Invest Ophthalmol Vis Sci 31 1990 964 967
24. J.J. Dutton, and E.G. Buckley Long-term results and complications of botulinum A toxin in the treatment of blepharospasm Ophthalmology 95 1988 1529 1534
25. R. Cakmur, V. Ozturk, and F. Uzunel Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm J Neurol 249 2002 64 68
26. G. Defazio, G. Abbruzzese, and P. Girlanda Botulinum toxin A treatment for primary hemifacial spasm: a ten year multicenter study Arch Neurol 59 2002 418 420
27. R.G. Auger Hemifacial spasm. Clinical and electrophysiologic observations Neurology 29 1979 1261
28. P.J. Janetta, M. Abbasy, and J.C. Maroon Etiology and definitive microsurgical treatment of hemifacial spasm J Neurosurg 47 1977 321
29. C. Sprik, and J.D. Wirtschafter Hemifacial spasm due to intracranial tumor. An international survey of botulinum toxin investigators Ophthalmology 95 1988 1042 1045
30. A.B. Scott Development of botulinum toxin therapy Dermatol Clin 22 2004 131 133
31. S.J. Stegman, T.A. Tromovitch, and R.G. Glogau Cosmetic dermatologic surgery 1990 Year Book Medical Publishers Chicago p. 5-15
32. S.R. Carter, and S.R. Seiff Cosmetic botulinum toxin injections Int Ophthalmol Clin 37 1997 69 79
33. J.A. Carruthers, N.J. Lowe, and M.A. Menter A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines J Am Acad Dermatol 46 2002 840 849
34. J.A. Foster, D. Barnhorst, and F. Papay The use of botulinum A toxin to ameliorate facial kinetic frown lines Ophthalmology 103 1996 618 622
35. M. Keen, A. Blitzer, and J. Aviv Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo controlled study Plast Reconst Surg 94 1994 94 99
36. N.J. Lowe, G. Lask, and P. Yamauchi Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet J Am Acad Dermatol 47 2002 834 840
37. B. Guyuron, and S.W. Huddleston Aesthetic indications for botulinum toxin injection Plast Reconstr Surg 93 1994 913 918